Luca Benatti

Luca Benatti

Founder chez NEWRON PHARMACEUTICALS S.P.A.

Fortune : 85 077 $ au 31/03/2024

63 ans
Health Technology
Commercial Services
Consumer Services

Profil

Luca Benatti is the founder of Newron Pharmaceuticals SpA, which was founded in 1998.
He is also the founder of Italian Angels For Biotech.
Dr. Benatti's current job is Chief Executive Officer & Director at EryDel SpA since 2012.
He is also a Director at Quince Therapeutics, Inc. since 2023.
Additionally, Dr. Benatti holds the position of Independent Director at Metis Precision Medicine Sb Srl and Principal at The European Association for Bioindustries.
Dr. Benatti's former positions include Vice Chairman at Assobiotec, Independent Director at Intercept Pharmaceuticals, Inc. from 2014 to 2023, and Head-Molecular Neurobiology Department at Pharmacia & Upjohn SpA in 1998.
He completed his undergraduate degree at the University of Milan.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
23/10/2023 80 261 ( 0,19% ) 85 077 $ 31/03/2024

Postes actifs de Luca Benatti

SociétésPosteDébut
NEWRON PHARMACEUTICALS S.P.A. Founder 01/01/1998
QUINCE THERAPEUTICS, INC. Director/Board Member 23/10/2023
The European Association for Bioindustries Corporate Officer/Principal 30/04/2010
Chief Executive Officer 01/06/2012
Director/Board Member -
Chairman -
Tous les postes actifs de Luca Benatti

Anciens postes connus de Luca Benatti

SociétésPosteFin
INTERCEPT PHARMACEUTICALS, INC. Director/Board Member 08/11/2023
Pharmacia & Upjohn SpA Corporate Officer/Principal 01/01/1998
Director/Board Member -
Voir l'expérience en détail de Luca Benatti

Formation de Luca Benatti

University of Milan Undergraduate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Luca Benatti

Relations

100 +

Relations au 1er degré

10

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées3
INTERCEPT PHARMACEUTICALS, INC.

Health Technology

NEWRON PHARMACEUTICALS S.P.A.

Health Technology

QUINCE THERAPEUTICS, INC.

Health Technology

Entreprise privées6

Health Technology

The European Association for Bioindustries

Commercial Services

Pharmacia & Upjohn SpA

Finance

Commercial Services

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Luca Benatti